Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 3 records per page: next > | last >>
pages: 1 2 3 presentations: 1 to 50 of 112
Harnessing Antibodies for HIV-1 Prevention and Treatment
John R. Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States
from CROI 2016 on February 23, 2016 8:30 AM-9:00 AM
Antiretroviral Therapy: Where Are We Now? Where Are We Going?
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2016 on February 23, 2016 9:00 AM-9:30 AM
Early Antiretroviral Therapy Does Not Improve Vascular Function: A START Substudy
Jason V. Baker
Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Comparing Cardiovascular Disease Risk Scores for Use in HIV-Infected Individuals
Heidi M. Crane
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Stroke Incidence Highest in Women and Black HIV-Infected Participants in ALLRT Cohort
Felicia Chow
University of California San Francisco, San Francisco, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Aspirin Fails to Impact Immune Activation or Endothelial Function in Treated HIV
Meagan K. O'Brien
Icahn School of Medicine at Mount Sinai, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Body Composition Changes on DRV/r + either RAL or TDF/FTC As First-Line ART
Jose I. Bernardino
Institute for Health Research of La Paz University Hospital, Madrid, Spain
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Antiretrovirals, Fractures, and Osteonecrosis in a Large European HIV Cohort
Alvaro H.D. Borges
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
A Single Dose Zoledronic Acid Prevents Antiretroviral-Induced Bone Loss
Ighovwerha Ofotokun
Emory University School of Medicine, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Recovery of Bone Mineral Density After Stopping Oral HIV Preexposure Prophylaxis
Robert Grant
University of California San Francisco, San Francisco, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures
Nicholas E. Webb
University of California Los Angeles, Los Angeles, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial
Elaine J. Abrams
ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program
Sundeep K. Gupta
Centers for Disease Control and Prevention, Lilongwe, Malawi
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral
George K. Siberry
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro
Harvard School of Public Health, Boston, MA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Urgent Versus Post-Stabilization ART in Hospitalized Children: A Randomized Trial
Lisa M. Cranmer
Emory University School of Medicine, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Three-Year Outcomes in PMTCT-Exposed Children Switched to EFV Once Suppressed on LPVr
Pamela Murnane
Columbia University, Johannesburg, South Africa
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Efavirenz Is Associated With Higher Bone Mass in South African Children With HIV
Stephen M. Arpadi
Columbia University Medical Center, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Rare Host Genetic Variation Influencing Risk of Heterosexual HIV-1 Acquisition
Romel D. Mackelprang
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs
Claudia Alteri
University of Rome Tor Vergata, Rome, Italy
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Identification of a Highly Functional DC Subset in Controllers by Single-Cell RNA-Seq
Enrique Martin-Gayo
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
The Sooty Mangabey Genome Sequence Reveals New Insights in Natural SIV Infections
David J. Palesch
Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Hyperacute Microbial Translocation During Pathogenic SIV Infection
Adam J. Ericsen
University of Wisconsin-Madison, Madison, WI, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
CD8 T Cells Are Required to Suppress Viremia in SIV-Infected ART Treated Macaques
Emily K. Cartwright
Emory University, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Lack of CTL Attenuates, but Does Not Ablate Compartmentalization of SIV Replication
Joy M. Folkvord
University of Colorado Anschutz Medical Campus, Aurora, CO, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Sooty Mangabey CD4+ T Cells Express the SIVsmm Coreceptor CXCR6
Katherine Wetzel
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Oral Abstract Moderator
Heidi van Rooyen
Human Sciences Research Council, Durban, South Africa
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Male Partner Home HIV Testing vs Clinic Invitation in Pregnancy: A Randomized Trial
Carey Farquhar
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Effectiveness of Partner Services for HIV in Kenya: A Cluster Randomized Trial
Peter Cherutich
University of Washington, Seattle, WA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Optimal Timing of Home-Based HIV Testing in Western Kenya
Jack J. Olney
Imperial College London, London, United Kingdom
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Estimating the Lifetime Risk of a Diagnosis of HIV Infection in the United States
Kristen Hess
Centers for Disease Control and Prevention, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Increased HIV Viral Suppression Among US Adults Receiving Medical Care, 2009-2013
Heather Bradley
Centers for Disease Control and Prevention, Atlanta, GA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals
Julia L. Marcus
Kaiser Permanente Northern California, Oakland, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257
Raphael J. Landovitz
David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Questions and Answers
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Oral Abstract Moderator
Alexandra L Calmy
University Hospital Geneva, University of Geneva, Geneva, Switzerland
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Safety, Immunologic and Virologic Activity of Anti-PD-L1 in HIV-1 Participants on ART
Joseph J. Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Effect of Sequential Vacc-4x/GM-CSF Immunization and Romidepsin on the HIV Reservoir
Ole Schmeltz Søgaard
Aarhus University Hospital, Aarhus, Denmark
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
A Patient Navigation/Contingency Management RCT for Hospitalized HIV+ Substance Users
Lisa R. Metsch
Columbia University Mailman School of Public Health, New York, NY, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Initiating ART at a Patient's First Clinic Visit: The RapIT Randomized Trial
Sydney Rosen
Boston University, Boston, MA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Switching Tenofovir DF to Tenofovir Alafenamide in Virologically Suppressed Adults
Joel Gallant
Southwest Care Center, Santa Fe, NM, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
ACTG 5273 Randomized Trial of Second-Line ART Supports WHO Guidance
Alberto M. La Rosa
Asociación Civil Impacta Salud y Educación, Lima, Peru
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Cabotegravir+Rilpivirine as Long-Acting Maintenance Therapy: LATTE-2 Week 32 Results
David A. Margolis
ViiV Healthcare, Research Triangle Park, NC, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
ACTG 5340:The Effect of VRC01 on Viral Kinetics After Analytic Treatment Interruption
Katharine J. Bar
University of Pennsylvania, Philadelphia, PA, United States
from CROI 2016 on February 23, 2016 10:00 AM-12:00 PM
Discussion of Oral Abstract Session 1 – SIV and HIV Pathogenesis and Oral Abstract Session 5 – Strategies for Testing and Linkage to Care: Are We Closing the Gap?
Chair
John Coffin
Tufts University, Medford, MA, United States
Chair
Susan P. Buchbinder
University of California, San Francisco, CA, United States
OA1: HIV-1 Laboratory Contagion During Recombination Procedures With Defective Constructs
Claudia Alteri
University of Rome Tor Vergata, Rome, Italy
OA5: Estimating the Lifetime Risk of a Diagnosis of HIV Infection in the United States
Kristen Hess
US Centers for Disease Control and Prevention, Atlanta, GA, United States
OA5: Increased HIV Viral Suppression Among US Adults Receiving Medical Care, 2009-2013
Heather Bradley
US Centers for Disease Control and Prevention, Atlanta, GA, United States
OA5: Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals
Julia L. Marcus
Kaiser Permanente Northern California, Oakland, CA, United States
OA5: Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257
Raphael J. Landovitz
David Geffen School of Medicine, University of California, Los Angeles, CA, United States
from CROI 2016 on February 23, 2016 12:30 PM-1:30 PM
Discussion of Oral Abstract Session 3 – Prevention and Treatment of Pediatric HIV Infections
OA3: National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program
Sundeep Gupta
CDC, Harare, Zimbabwe
OA3: Impact of Maternal Tenofovir Use on HIV-Exposed Newborn Bone Mineral
George K. Siberry
Eunice Kennedy Shriver NICHD, Bethesda, MD, United States
OA3: Similar Mortality With Cotrimoxazole vs Placebo in HIV-Exposed Uninfected Children
Roger L. Shapiro
Harvard School of Public Health, Boston, MA, United States
Chair
Elaine J. Abrams
Columbia University, New York, NY, United States
OA3: Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial
Harriet Nuwagaba-Biribonwoha
ICAP, Columbia University Mailman School of Public Health, New York, NY, United States
from CROI 2016 on February 23, 2016 12:30 PM-1:30 PM
Themed Discussion Leader
David M Burger
Radboud University Medical Center, Nijmegen, Netherlands
from CROI 2016 on February 23, 2016 1:45 PM-2:45 PM
Dolutegravir Pharmacokinetics in HIV-Infected Pregnant and Postpartum Women
Nikki Mulligan
University of California San Diego, San Diego, CA, United States
from CROI 2016 on February 23, 2016 1:45 PM-2:45 PM
Rilpivirine Female Genital Tract Concentrations in Pregnant and Postpartum Women
Brookie M. Best
University of California San Diego, San Diego, CA, United States
from CROI 2016 on February 23, 2016 1:45 PM-2:45 PM
Nevirapine Dosing for Treatment in the First Month of Life
Mark Mirochnick
Boston University School of Medicine, Boston, MA, United States
from CROI 2016 on February 23, 2016 1:45 PM-2:45 PM
<< first | < prev page: of 3 records per page: next > | last >>
pages: 1 2 3 presentations: 1 to 50 of 112